Literature DB >> 23954950

Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway.

Yanzhang Li1, Xinyu Qi, Xiaopeng Tong, Shuxia Wang.   

Abstract

Previously, we demonstrated that macrophages from thrombospondin 1 (TSP1)-deficient mice have a reduced inflammatory phenotype, suggesting that TSP1 plays a role in macrophage activation. In this study, we determined how TSP1 regulates macrophage function. We found that recombinant or purified platelet human TSP1 treatment stimulated tumor-necrosis factor (TNF)-α expression in bone marrow-derived macrophages in a time- and dose-dependent manner. Toll-like receptor 4 (TLR4) expression (at the mRNA and protein levels) and nuclear factor-kappaB (NF-κB) activity were also stimulated by TSP1 treatment. The TSP1-mediated increase in TNF-α production was abolished in TLR4-deficient macrophages, suggesting that TSP1 activates macrophages through a TLR4-dependent pathway. TSP1 also stimulated TLR4 activation in macrophages in vivo. Furthermore, TSP1-mediated macrophage activation was attenuated by using a peptide or an antibody to block the association between TSP1 and CD36. Taken together, these data suggest that the stimulation of the macrophage TLR4 pathway by TSP1 is partially mediated by the interaction of TSP1 with its receptor, CD36.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23954950      PMCID: PMC3818315          DOI: 10.1038/cmi.2013.32

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  39 in total

Review 1.  Thrombospondins as matricellular modulators of cell function.

Authors:  P Bornstein
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.

Authors:  I Mikhailenko; D Krylov; K M Argraves; D D Roberts; G Liau; D K Strickland
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36.

Authors:  S Frieda; A Pearce; J Wu; R L Silverstein
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

4.  Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.

Authors:  Prasad Rallabhandi; Jessica Bell; Marina S Boukhvalova; Andrei Medvedev; Eva Lorenz; Moshe Arditi; Val G Hemming; Jorge C G Blanco; David M Segal; Stefanie N Vogel
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Thrombospondin-4 regulates vascular inflammation and atherogenesis.

Authors:  Ella G Frolova; Elzbieta Pluskota; Irene Krukovets; Tim Burke; Carla Drumm; Jonathan D Smith; Lauren Blech; Maria Febbraio; Paul Bornstein; Edward F Plow; Olga I Stenina
Journal:  Circ Res       Date:  2010-09-30       Impact factor: 17.367

6.  Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin.

Authors:  S Goicoechea; A W Orr; M A Pallero; P Eggleton; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells.

Authors:  M W Phelan; L W Forman; S P Perrine; D V Faller
Journal:  J Lab Clin Med       Date:  1998-12

8.  Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.

Authors:  Shuxia Wang; Mary E Herndon; Sripriya Ranganathan; Svetlana Godyna; Jack Lawler; W Scott Argraves; Gene Liau
Journal:  J Cell Biochem       Date:  2004-03-01       Impact factor: 4.429

9.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

10.  Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains.

Authors:  G Taraboletti; D D Roberts; L A Liotta
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  27 in total

Review 1.  Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression.

Authors:  H Chkourko Gusky; J Diedrich; O A MacDougald; I Podgorski
Journal:  Obes Rev       Date:  2016-07-19       Impact factor: 9.213

2.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

4.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 5.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

6.  Antiangiogenic VEGF165b Regulates Macrophage Polarization via S100A8/S100A9 in Peripheral Artery Disease.

Authors:  Vijay Chaitanya Ganta; Min Choi; Charles R Farber; Brian H Annex
Journal:  Circulation       Date:  2019-01-08       Impact factor: 29.690

7.  Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Qi Zhou; Heather Norman; Changcheng Zhou; Shuxia Wang
Journal:  Biochim Biophys Acta       Date:  2015-03-31

8.  Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice.

Authors:  Hasiyet Memetimin; Dong Li; Kaiyuan Tan; Changcheng Zhou; Ying Liang; Yadi Wu; Shuxia Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

Review 9.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

10.  Thrombospondin 1 Suppresses Insulin Signaling in C2C12 Myotubes.

Authors:  Kaku Matsugi; Tetsuya Hosooka; Kazuhiro Nomura; Wataru Ogawa
Journal:  Kobe J Med Sci       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.